| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.648 | 3.985 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 12.667 | 3.985 | 0 | 0 | 0 | 0 | 0 | 0 | 11.119 | 0 |
| Total Expenses - EUR | 20.787 | 5.736 | 1.216 | 647 | 750 | 736 | 834 | 143 | 19.600 | 5.379 |
| Gross Profit/Loss - EUR | -8.120 | -1.751 | -1.216 | -647 | -750 | -736 | -834 | -143 | -8.481 | -5.379 |
| Net Profit/Loss - EUR | -8.500 | -1.871 | -1.216 | -647 | -750 | -736 | -834 | -143 | -8.481 | -5.379 |
| Employees | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nouvalmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.409 | 0 |
| Current Assets | 28.621 | 23.007 | 22.212 | 21.928 | 21.645 | 21.375 | 21.059 | 21.152 | 11.795 | 11.729 |
| Inventories | 24.238 | 20.895 | 20.542 | 20.165 | 19.774 | 19.399 | 18.969 | 19.028 | 0 | 0 |
| Receivables | 1.786 | 1.548 | 1.620 | 1.713 | 1.822 | 1.928 | 2.043 | 2.077 | 11.748 | 11.683 |
| Cash | 2.597 | 564 | 51 | 50 | 49 | 48 | 47 | 47 | 47 | 47 |
| Shareholders Funds | -94.260 | -95.169 | -94.775 | -93.683 | -92.618 | -91.599 | -90.402 | -90.826 | -99.031 | -103.857 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 122.881 | 118.176 | 116.987 | 115.611 | 114.264 | 112.974 | 111.461 | 111.978 | 116.236 | 115.587 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Nouvalmed Srl